CETIIRIZINE

CETIIRIZINE was reported 43264 times

CETIIRIZINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID ARTHROPATHY 58 0.8286
1 RADIATION INFLAMMATION 36 0.4500
2 GRIP STRENGTH 99 0.4323
3 C-REACTIVE PROTEIN 371 0.4002
4 VAGINAL FLATULENCE 118 0.3894
5 SWOLLEN JOINT COUNT 94 0.3760
6 DUODENAL ULCER PERFORATION 2688 0.3611
7 DEEP VEIN THROMBOSIS POSTOPERATIVE 710 0.3545
8 FACET JOINT SYNDROME 1137 0.3489
9 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2442 0.3405
10 SWOLLEN JOINT COUNT INCREASED 1082 0.3390
11 RHEUMATIC FEVER 1464 0.3281
12 LUPUS VULGARIS 401 0.3183
13 MUSCLE INJURY 2531 0.3052
14 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1859 0.2860
15 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 191 0.2859
16 CARDIOSPASM 154 0.2760
17 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 150 0.2674
18 FOLLICULITIS 2786 0.2654
19 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 550 0.2652
20 HELICOBACTER INFECTION 2599 0.2526
21 PEMPHIGUS 2993 0.2392
22 DISLOCATION OF VERTEBRA 531 0.2326
23 RHEUMATOID FACTOR POSITIVE 1315 0.2274
24 IMMUNISATION 96 0.2212
25 X-RAY ABNORMAL 387 0.2162
26 HAND DEFORMITY 2771 0.2111
27 HEPATIC ENZYME 31 0.2081
28 PALMOPLANTAR KERATODERMA 148 0.2041
29 HYPOCHOLESTEROLAEMIA 71 0.2011
30 PERIPHERAL VENOUS DISEASE 822 0.2011
31 RETINITIS 340 0.1966
32 PERICARDITIS 2887 0.1717
33 C-REACTIVE PROTEIN ABNORMAL 1033 0.1609
34 SYNOVITIS 2792 0.1547
35 BREAST CANCER STAGE III 891 0.1374
36 PORPHYRIA ACUTE 190 0.1324
37 GLOSSODYNIA 2933 0.1309
38 IRRITABLE BOWEL SYNDROME 2752 0.1282
39 OVERLAP SYNDROME 89 0.1271
40 LIP DRY 1087 0.1196
41 TEMPERATURE REGULATION DISORDER 253 0.1135
42 SERONEGATIVE ARTHRITIS 126 0.1099
43 BURSITIS 1224 0.1008
44 JOINT RANGE OF MOTION DECREASED 1306 0.0973
45 WOUND 2699 0.0965
46 ONYCHOMADESIS 404 0.0962
47 WOUND INFECTION 1008 0.0920
48 LIVE BIRTH 770 0.0920
49 BLEPHAROSPASM 566 0.0898
50 BONE EROSION 316 0.0893
51 SYSTEMIC LUPUS ERYTHEMATOSUS 3129 0.0881
52 IMPAIRED HEALING 2784 0.0847
53 CHRONIC SPONTANEOUS URTICARIA 97 0.0836
54 GRIP STRENGTH DECREASED 724 0.0822
55 HYPERCHOLESTEROLAEMIA 774 0.0801
56 CONTRAINDICATED PRODUCT ADMINISTERED 2316 0.0764
57 PRURITUS GENITAL 178 0.0755
58 AUTOIMMUNE DISORDER 731 0.0749
59 ATRIAL TACHYCARDIA 153 0.0728
60 FEMALE GENITAL TRACT FISTULA 123 0.0720
61 MATERNAL EXPOSURE TIMING UNSPECIFIED 270 0.0718
62 JOINT DESTRUCTION 111 0.0713
63 FIBROMYALGIA 1660 0.0682
64 LOWER RESPIRATORY TRACT INFECTION 2977 0.0654
65 INFUSION SITE REACTION 188 0.0629
66 OBESITY 1001 0.0628
67 DRUG TOLERANCE DECREASED 176 0.0626
68 URTICARIA CHRONIC 35 0.0624
69 ONYCHOMYCOSIS 264 0.0601
70 VOCAL CORD DYSFUNCTION 29 0.0588
71 VICTIM OF CHEMICAL SUBMISSION 39 0.0581
72 TYPE 2 DIABETES MELLITUS 1829 0.0543
73 BLISTER 2946 0.0524
74 LIVER INJURY 1279 0.0521
75 DEATH NEONATAL 71 0.0510
76 NAIL DISORDER 439 0.0501
77 INFUSION RELATED REACTION 3283 0.0495
78 ARTHROPATHY 2748 0.0494
79 PROCTITIS 137 0.0489
80 THERAPEUTIC PRODUCT EFFECT DECREASED 2182 0.0487
81 STOMATITIS 2950 0.0486
82 FOOD ALLERGY 368 0.0476
83 SLEEP TERROR 199 0.0472
84 COELIAC DISEASE 463 0.0472
85 RADICULOPATHY 124 0.0470
86 SCIATICA 749 0.0469
87 PUSTULAR PSORIASIS 160 0.0465
88 PRESCRIBED OVERDOSE 885 0.0457
89 EXOSTOSIS 416 0.0455
90 CHRONIC SINUSITIS 170 0.0452
91 HEPATIC ENZYME INCREASED 2974 0.0436
92 NONINFECTIVE GINGIVITIS 63 0.0435
93 FINGER DEFORMITY 208 0.0429
94 PSORIATIC ARTHROPATHY 1725 0.0425
95 WALKING AID USER 280 0.0424
96 ELECTRIC SHOCK 36 0.0420
97 CAROTID ARTERY OCCLUSION 151 0.0413
98 RESTRICTIVE PULMONARY DISEASE 48 0.0410
99 MAST CELL ACTIVATION SYNDROME 57 0.0406
100 PULMONARY PAIN 118 0.0404
101 DISCOMFORT 2385 0.0391
102 NIGHT SWEATS 1256 0.0389
103 SWELLING 3606 0.0385
104 LUPUS-LIKE SYNDROME 348 0.0383
105 LOWER LIMB FRACTURE 715 0.0372
106 ILL-DEFINED DISORDER 2260 0.0372
107 BACK INJURY 403 0.0370
108 VITAMIN B12 INCREASED 29 0.0364
109 PULMONARY FIBROSIS 697 0.0363
110 TENSION HEADACHE 156 0.0362
111 FOETAL DEATH 188 0.0362
112 CHRONIC FATIGUE SYNDROME 50 0.0359
113 RASH VESICULAR 173 0.0357
114 WHEEZING 2052 0.0346
115 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 31 0.0334
116 GAIT INABILITY 1109 0.0331
117 FORCED EXPIRATORY VOLUME DECREASED 92 0.0324
118 HIP ARTHROPLASTY 496 0.0324
119 RED BLOOD CELL SEDIMENTATION RATE INCREASED 354 0.0320
120 APLASTIC ANAEMIA 164 0.0314
121 BLOOD IMMUNOGLOBULIN E INCREASED 76 0.0314
122 BLOOD CHOLESTEROL INCREASED 1440 0.0309
123 BREAST CANCER STAGE II 256 0.0307
124 FOOT DEFORMITY 335 0.0302
125 JOINT SWELLING 3614 0.0299
126 CONGENITAL ANOMALY 229 0.0296
127 OSTEOARTHRITIS 1251 0.0295
128 RHEUMATOID ARTHRITIS 3237 0.0285
129 SINUSITIS 2913 0.0284
130 JOINT DISLOCATION 298 0.0282
131 IMMUNODEFICIENCY 416 0.0279
132 TASTE DISORDER 563 0.0277
133 ULCER HAEMORRHAGE 187 0.0276
134 DACTYLITIS 27 0.0275
135 SLEEP DISORDER 1940 0.0275
136 PRODUCT LABEL CONFUSION 160 0.0274
137 DRUG INTOLERANCE 2640 0.0273
138 GASTROINTESTINAL DISORDER 2418 0.0270
139 KNEE ARTHROPLASTY 568 0.0270
140 EAR PAIN 517 0.0266
141 DRUG TOLERANCE 131 0.0259
142 MATERNAL EXPOSURE DURING PREGNANCY 2293 0.0257
143 TYPE I HYPERSENSITIVITY 87 0.0247
144 FIXED ERUPTION 42 0.0244
145 NORMAL NEWBORN 132 0.0243
146 INFLAMMATION 1253 0.0243
147 EPILEPSY 741 0.0242
148 SPONDYLITIS 88 0.0242
149 MUSCLE SPASTICITY 297 0.0241
150 LABYRINTHITIS 61 0.0241
151 PREGNANCY 481 0.0240
152 INJURY 1687 0.0240
153 MOBILITY DECREASED 1688 0.0235
154 FACIAL PAIN 209 0.0234
155 OSTEITIS 59 0.0234
156 INTERVERTEBRAL DISCITIS 44 0.0233
157 LUNG DISORDER 1133 0.0231
158 CONTUSION 2203 0.0229
159 MACULAR DEGENERATION 272 0.0228
160 C-REACTIVE PROTEIN INCREASED 822 0.0226
161 LIVER FUNCTION TEST INCREASED 481 0.0224
162 PERIPHERAL SWELLING 3372 0.0219
163 OEDEMA 1184 0.0218
164 POLYARTHRITIS 113 0.0214
165 ROAD TRAFFIC ACCIDENT 891 0.0213
166 ABDOMINAL DISCOMFORT 3549 0.0211
167 INFECTION 2974 0.0205
168 HYPERSENSITIVITY 3788 0.0204
169 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 47 0.0204
170 SUBARACHNOID HAEMORRHAGE 206 0.0202
171 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 343 0.0202
172 MYOSITIS 181 0.0202
173 PRESCRIBED UNDERDOSE 402 0.0201
174 EYE INJURY 61 0.0201
175 DRY MOUTH 1628 0.0200
176 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 109 0.0200
177 URTICARIA 3353 0.0200
178 MUSCULOSKELETAL PAIN 1043 0.0199
179 GENITAL PAIN 29 0.0196
180 TREATMENT FAILURE 1622 0.0196
181 ASPARTATE AMINOTRANSFERASE ABNORMAL 29 0.0190
182 CONFUSIONAL STATE 3075 0.0190
183 GENERAL PHYSICAL HEALTH DETERIORATION 2178 0.0188
184 HEPATIC CIRRHOSIS 352 0.0187
185 DELIRIUM 650 0.0187
186 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 38 0.0186
187 GENERAL SYMPTOM 139 0.0185
188 RESPIRATORY DISORDER 552 0.0184
189 LIVER DISORDER 812 0.0183
190 ANGIOEDEMA 803 0.0181
191 INTENTIONAL PRODUCT USE ISSUE 1585 0.0181
192 TERMINAL INSOMNIA 32 0.0181
193 EXPOSURE DURING PREGNANCY 1110 0.0178
194 BODY TEMPERATURE INCREASED 361 0.0177
195 OBSTRUCTIVE AIRWAYS DISORDER 195 0.0175
196 MUSCULOSKELETAL STIFFNESS 1533 0.0175
197 LOOSE TOOTH 56 0.0174
198 BRONCHIAL DISORDER 27 0.0174
199 DRUG-INDUCED LIVER INJURY 538 0.0171
200 WHITE BLOOD CELLS URINE POSITIVE 32 0.0170
201 ALOPECIA 3340 0.0170
202 NASOPHARYNGITIS 3111 0.0169
203 THERAPY NON-RESPONDER 756 0.0168
204 ASTHMA 1886 0.0167
205 JOINT NOISE 32 0.0163
206 EAR INFECTION 431 0.0162
207 LIP SWELLING 536 0.0161
208 ADRENAL INSUFFICIENCY 193 0.0159
209 SEDATION COMPLICATION 40 0.0157
210 REBOUND ACID HYPERSECRETION 47 0.0155
211 GASTROINTESTINAL HYPOMOTILITY 35 0.0155
212 PARAESTHESIA ORAL 222 0.0154
213 HYPERPARATHYROIDISM SECONDARY 38 0.0152
214 VASCULITIS 176 0.0151
215 SPINAL FUSION SURGERY 61 0.0150
216 ORAL PRURITUS 34 0.0148
217 FREQUENT BOWEL MOVEMENTS 395 0.0146
218 UPPER RESPIRATORY TRACT INFECTION 672 0.0145
219 WEIGHT INCREASED 3190 0.0142
220 JOINT STIFFNESS 369 0.0141
221 VITAMIN B12 DECREASED 40 0.0139
222 MIGRAINE 1315 0.0138
223 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 236 0.0138
224 SUSPECTED OFF LABEL USE 61 0.0135
225 DISABILITY 267 0.0135
226 MONOCYTE COUNT INCREASED 49 0.0135
227 VAGINAL DISCHARGE 135 0.0133
228 AMNESIA 854 0.0131
229 ANOSMIA 190 0.0131
230 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 616 0.0128
231 MUSCLE TWITCHING 293 0.0127
232 RHINOVIRUS INFECTION 49 0.0126
233 RHINITIS ALLERGIC 56 0.0126
234 ORAL CANDIDIASIS 165 0.0125
235 RHINITIS 101 0.0125
236 OSTEOPOROSIS 515 0.0125
237 HYPOAESTHESIA 1871 0.0125
238 MOUTH SWELLING 72 0.0125
239 WEIGHT FLUCTUATION 124 0.0118
240 MATERNAL EXPOSURE DURING BREAST FEEDING 48 0.0118
241 PRURITUS 4541 0.0118
242 RASH 5123 0.0117
243 DEMYELINATION 48 0.0117
244 DYSPEPSIA 1151 0.0117
245 NEPHROGENIC ANAEMIA 54 0.0116
246 HALLUCINATIONS, MIXED 49 0.0116
247 CYSTIC FIBROSIS 64 0.0115
248 PYREXIA 3959 0.0114
249 MEDICATION ERROR 626 0.0113
250 HYPERTENSION 2379 0.0112
251 ANGIOPATHY 62 0.0111
252 ABDOMINAL PAIN UPPER 2219 0.0108
253 BRADYPNOEA 29 0.0107
254 CUTANEOUS VASCULITIS 39 0.0107
255 SKIN PLAQUE 90 0.0107
256 VENTRICULAR TACHYCARDIA 176 0.0106
257 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 28 0.0105
258 MUSCULAR WEAKNESS 1196 0.0105
259 RASH MORBILLIFORM 29 0.0105
260 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 733 0.0103
261 PHARYNGEAL SWELLING 100 0.0102
262 ATTENTION DEFICIT HYPERACTIVITY DISORDER 43 0.0102
263 BLOOD PRESSURE DIASTOLIC INCREASED 47 0.0102
264 THROAT CLEARING 38 0.0101
265 BACK DISORDER 163 0.0100
266 CYTOKINE RELEASE SYNDROME 200 0.0100
267 WOUND SECRETION 39 0.0099
268 GASTROOESOPHAGEAL REFLUX DISEASE 792 0.0098
269 ARTHRALGIA 4078 0.0098
270 MEMORY IMPAIRMENT 1344 0.0098
271 HEPATITIS 250 0.0098
272 RASH ERYTHEMATOUS 467 0.0098
273 PULMONARY FUNCTION TEST DECREASED 42 0.0096
274 ADVERSE REACTION 127 0.0096
275 BRONCHIECTASIS 64 0.0095
276 RECTAL HAEMORRHAGE 408 0.0095
277 NECK PAIN 523 0.0093
278 ANAPHYLACTIC REACTION 514 0.0093
279 SEASONAL ALLERGY 131 0.0092
280 POST-TRAUMATIC STRESS DISORDER 62 0.0092
281 COLITIS ULCERATIVE 413 0.0092
282 PRODUCT USE ISSUE 1719 0.0091
283 FLUID RETENTION 465 0.0091
284 MYDRIASIS 117 0.0091
285 PARAESTHESIA 1411 0.0090
286 COORDINATION ABNORMAL 124 0.0089
287 INSOMNIA 2349 0.0088
288 HYPERVENTILATION 51 0.0088
289 BLOOD PRESSURE SYSTOLIC DECREASED 40 0.0088
290 SWOLLEN TONGUE 272 0.0087
291 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 67 0.0086
292 CONDITION AGGRAVATED 2609 0.0086
293 EOSINOPHILIA 149 0.0085
294 TOOTH FRACTURE 93 0.0084
295 PAIN 5156 0.0084
296 EYE PRURITUS 282 0.0084
297 DEPRESSION SUICIDAL 29 0.0084
298 CHEST PAIN 1547 0.0083
299 IMPAIRED QUALITY OF LIFE 120 0.0083
300 MULTIPLE ALLERGIES 65 0.0083
301 FULL BLOOD COUNT ABNORMAL 87 0.0082
302 FEELING HOT 503 0.0082
303 DYSPNOEA 4627 0.0082
304 VITAMIN B12 DEFICIENCY 33 0.0081
305 RALES 47 0.0081
306 TACHYCARDIA 719 0.0081
307 EOSINOPHIL COUNT INCREASED 67 0.0080
308 UPPER-AIRWAY COUGH SYNDROME 66 0.0080
309 FLANK PAIN 75 0.0080
310 BLOOD PRESSURE DIASTOLIC DECREASED 59 0.0080
311 INTENTIONAL PRODUCT MISUSE 699 0.0080
312 BLOOD CALCIUM DECREASED 89 0.0079
313 SYMPTOM RECURRENCE 47 0.0078
314 TENDON DISORDER 51 0.0078
315 MIDDLE INSOMNIA 146 0.0078
316 MUSCLE FATIGUE 33 0.0078
317 OEDEMA PERIPHERAL 937 0.0077
318 SCRATCH 81 0.0077
319 SNORING 29 0.0077
320 MUSCLE SPASMS 1403 0.0076
321 MUCOSAL INFLAMMATION 199 0.0076
322 RASH PAPULAR 170 0.0076
323 TEMPERATURE INTOLERANCE 78 0.0076
324 GESTATIONAL DIABETES 36 0.0075
325 DIPLOPIA 196 0.0075
326 FATIGUE 5851 0.0075
327 SWELLING FACE 488 0.0075
328 VITAMIN D DEFICIENCY 73 0.0075
329 HYPOKALAEMIA 345 0.0075
330 HYPERTHERMIA 57 0.0075
331 SMALL FOR DATES BABY 37 0.0074
332 HYPERTRANSAMINASAEMIA 51 0.0073
333 DISTURBANCE IN ATTENTION 395 0.0073
334 SPUTUM DISCOLOURED 69 0.0073
335 PAPULE 51 0.0072
336 WHITE BLOOD CELL COUNT INCREASED 277 0.0072
337 COGNITIVE DISORDER 336 0.0072
338 ADVERSE EVENT 659 0.0071
339 DEPRESSION 1623 0.0071
340 RESPIRATORY ACIDOSIS 28 0.0071
341 RASH MACULO-PAPULAR 158 0.0071
342 FOOD POISONING 38 0.0071
343 FEELING OF DESPAIR 33 0.0071
344 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 182 0.0071
345 SOMNAMBULISM 46 0.0070
346 SWELLING OF EYELID 44 0.0070
347 VOMITING 3273 0.0070
348 PAIN OF SKIN 187 0.0069
349 ADVERSE DRUG REACTION 617 0.0069
350 PROCTALGIA 44 0.0068
351 EXERCISE TOLERANCE DECREASED 39 0.0068
352 PRODUCTIVE COUGH 323 0.0068
353 DECREASED APPETITE 1570 0.0068
354 SPINAL DISORDER 64 0.0068
355 COLITIS MICROSCOPIC 32 0.0067
356 ARTHRITIS 529 0.0067
357 HYPERHIDROSIS 866 0.0067
358 TONSILLITIS 35 0.0067
359 SENSITIVITY TO WEATHER CHANGE 35 0.0066
360 GASTROENTERITIS VIRAL 120 0.0066
361 IMPAIRED GASTRIC EMPTYING 90 0.0066
362 END STAGE RENAL DISEASE 119 0.0065
363 TOXIC EPIDERMAL NECROLYSIS 99 0.0065
364 ABDOMINAL PAIN 1509 0.0065
365 TRANSIENT ISCHAEMIC ATTACK 217 0.0064
366 ANXIETY 1820 0.0064
367 TRANSFUSION 67 0.0064
368 FEBRILE NEUTROPENIA 422 0.0064
369 DERMATITIS ALLERGIC 80 0.0064
370 HEPATOCELLULAR INJURY 90 0.0063
371 PRODUCT USE IN UNAPPROVED INDICATION 1571 0.0063
372 RASH PRURITIC 342 0.0063
373 BRUXISM 34 0.0063
374 PRURITUS GENERALISED 136 0.0063
375 THROAT TIGHTNESS 169 0.0062
376 PROCEDURAL PAIN 173 0.0062
377 SINUS CONGESTION 84 0.0062
378 DECREASED IMMUNE RESPONSIVENESS 61 0.0062
379 MALAISE 2724 0.0062
380 PNEUMONIA 1996 0.0062
381 BLOOD MAGNESIUM DECREASED 53 0.0061
382 CHRONIC KIDNEY DISEASE 465 0.0061
383 TINNITUS 280 0.0061
384 UROSEPSIS 56 0.0061
385 SYNOVIAL CYST 28 0.0061
386 TIC 33 0.0060
387 EMPHYSEMA 61 0.0060
388 PHARYNGITIS 75 0.0060
389 ASTHENIA 2273 0.0060
390 INFUSION SITE SWELLING 38 0.0060
391 SKIN REACTION 85 0.0060
392 PSORIASIS 788 0.0060
393 HYPOMAGNESAEMIA 84 0.0060
394 CHOLECYSTITIS ACUTE 34 0.0060
395 RESPIRATORY RATE INCREASED 53 0.0060
396 POISONING 75 0.0060
397 HEREDITARY ANGIOEDEMA 64 0.0060
398 PEMPHIGOID 45 0.0060
399 NEUTROPHIL COUNT INCREASED 61 0.0060
400 HEADACHE 3706 0.0059
401 JAUNDICE 159 0.0059
402 SECRETION DISCHARGE 74 0.0059
403 DEPRESSED MOOD 310 0.0059
404 COLITIS 222 0.0059
405 MIOSIS 47 0.0059
406 RIGHT VENTRICULAR FAILURE 41 0.0058
407 SLUGGISHNESS 59 0.0058
408 NASAL CONGESTION 339 0.0058
409 WITHDRAWAL SYNDROME 242 0.0058
410 LABORATORY TEST ABNORMAL 170 0.0058
411 RESPIRATORY TRACT INFECTION 150 0.0058
412 PHOTOSENSITIVITY REACTION 95 0.0057
413 NEUTROPENIC SEPSIS 41 0.0057
414 SINUS HEADACHE 34 0.0057
415 CHEST DISCOMFORT 584 0.0057
416 HEPATITIS ACUTE 37 0.0057
417 GAIT DISTURBANCE 1082 0.0056
418 INJECTION SITE REACTION 387 0.0056
419 THROAT IRRITATION 249 0.0055
420 BLOOD URIC ACID INCREASED 32 0.0055
421 VISUAL IMPAIRMENT 686 0.0055
422 GINGIVAL PAIN 44 0.0055
423 BREATH SOUNDS ABNORMAL 27 0.0055
424 PETECHIAE 57 0.0055
425 INFUSION SITE EXTRAVASATION 34 0.0055
426 INFUSION SITE ERYTHEMA 46 0.0055
427 SLEEP APNOEA SYNDROME 104 0.0054
428 RETCHING 116 0.0054
429 HEART RATE INCREASED 538 0.0054
430 TRISMUS 28 0.0054
431 GASTROINTESTINAL MOTILITY DISORDER 29 0.0054
432 DIARRHOEA 3493 0.0054
433 PAIN IN EXTREMITY 1586 0.0054
434 HALLUCINATION 405 0.0054
435 ATRIAL SEPTAL DEFECT 45 0.0054
436 BREAST MASS 36 0.0054
437 BRADYPHRENIA 35 0.0054
438 DIZZINESS 2652 0.0053
439 BRONCHITIS 392 0.0053
440 OFF LABEL USE 4629 0.0053
441 RESPIRATORY SYNCYTIAL VIRUS INFECTION 46 0.0053
442 BLOOD PRESSURE SYSTOLIC INCREASED 103 0.0053
443 ULCER 84 0.0053
444 MOUTH ULCERATION 111 0.0053
445 OXYGEN SATURATION DECREASED 296 0.0053
446 BRADYKINESIA 31 0.0052
447 BRAIN FOG 82 0.0052
448 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 43 0.0052
449 BACK PAIN 1209 0.0052
450 OROPHARYNGEAL DISCOMFORT 47 0.0052
451 BODY TEMPERATURE DECREASED 51 0.0052
452 POISONING DELIBERATE 49 0.0052
453 THROMBOCYTOPENIA 578 0.0052
454 BLOOD COUNT ABNORMAL 78 0.0051
455 ECZEMA 269 0.0051
456 HYPOTHERMIA 52 0.0051
457 PERIORBITAL SWELLING 29 0.0051
458 BLOOD PRESSURE FLUCTUATION 123 0.0051
459 PURPURA 45 0.0051
460 ERYTHEMA 1045 0.0051
461 DRUG ABUSE 423 0.0051
462 QUALITY OF LIFE DECREASED 68 0.0051
463 DROOLING 35 0.0051
464 ANHEDONIA 133 0.0051
465 HYPOAESTHESIA ORAL 76 0.0050
466 ASPIRATION 55 0.0050
467 INTENTIONAL SELF-INJURY 101 0.0050
468 OBSESSIVE-COMPULSIVE DISORDER 40 0.0050
469 FOETAL EXPOSURE DURING PREGNANCY 405 0.0050
470 DERMATITIS BULLOUS 36 0.0050
471 RESPIRATORY TRACT CONGESTION 79 0.0050
472 TOXIC SKIN ERUPTION 50 0.0050
473 PALPITATIONS 579 0.0049
474 PRESYNCOPE 120 0.0049
475 LACRIMATION INCREASED 149 0.0049
476 DERMATITIS CONTACT 56 0.0049
477 SKIN INFECTION 55 0.0049
478 BLOOD UREA INCREASED 82 0.0049
479 ANAPHYLACTIC SHOCK 126 0.0049
480 ELECTROCARDIOGRAM QT PROLONGED 174 0.0048
481 COVID-19 PNEUMONIA 57 0.0048
482 ACUTE KIDNEY INJURY 737 0.0048
483 SNEEZING 108 0.0048
484 SKIN LESION 132 0.0048
485 TOOTH ABSCESS 49 0.0048
486 TUBULOINTERSTITIAL NEPHRITIS 90 0.0048
487 DRUG ERUPTION 85 0.0048
488 CARDIAC FLUTTER 31 0.0048
489 NASAL DRYNESS 30 0.0048
490 PHARYNGEAL OEDEMA 73 0.0047
491 CONJUNCTIVITIS 88 0.0047
492 THERAPEUTIC RESPONSE DECREASED 287 0.0047
493 WEIGHT DECREASED 1316 0.0047
494 SCREAMING 30 0.0047
495 DEFAECATION URGENCY 33 0.0047
496 OSTEOPENIA 71 0.0047
497 ABDOMINAL DISTENSION 488 0.0047
498 NODULE 61 0.0047
499 NAUSEA 3699 0.0047
500 DYSPNOEA EXERTIONAL 175 0.0046
501 SINUS DISORDER 92 0.0046
502 HYPOALBUMINAEMIA 36 0.0046
503 CONSTIPATION 1007 0.0046
504 REBOUND EFFECT 52 0.0046
505 FACE OEDEMA 77 0.0046
506 BLINDNESS 186 0.0046
507 ORAL PAIN 102 0.0046
508 NIGHTMARE 156 0.0045
509 PANCREATITIS 238 0.0045
510 HYPONATRAEMIA 253 0.0045
511 BRONCHOSPASM 64 0.0045
512 GASTROINTESTINAL PAIN 49 0.0044
513 STEVENS-JOHNSON SYNDROME 99 0.0044
514 DISORIENTATION 176 0.0044
515 COVID-19 779 0.0044
516 URINARY INCONTINENCE 131 0.0044
517 HYPOTONIA 44 0.0044
518 URINARY RETENTION 147 0.0044
519 CIRCULATORY COLLAPSE 75 0.0044
520 HYPOCALCAEMIA 83 0.0044
521 RASH MACULAR 153 0.0044
522 DRUG INTERACTION 694 0.0044
523 ACUTE RESPIRATORY FAILURE 84 0.0044
524 UNDERDOSE 318 0.0044
525 HAEMATOCHEZIA 240 0.0043
526 CHROMATURIA 98 0.0043
527 CEREBRAL DISORDER 32 0.0043
528 AFFECTIVE DISORDER 34 0.0043
529 COUGH 1210 0.0043
530 RESTLESS LEGS SYNDROME 78 0.0043
531 INFUSION SITE PAIN 55 0.0043
532 MANIA 70 0.0043
533 SPINAL OSTEOARTHRITIS 37 0.0042
534 FRUSTRATION TOLERANCE DECREASED 34 0.0042
535 EAR DISCOMFORT 43 0.0042
536 ARTHROPOD BITE 31 0.0042
537 FEELING DRUNK 31 0.0042
538 DECREASED ACTIVITY 45 0.0042
539 HIATUS HERNIA 54 0.0042
540 POOR VENOUS ACCESS 43 0.0042
541 SOPOR 55 0.0041
542 HYPERKALAEMIA 145 0.0041
543 TENDERNESS 43 0.0041
544 PHOTOPHOBIA 77 0.0041
545 HYPOXIA 144 0.0041
546 DYSPHAGIA 388 0.0041
547 EYE SWELLING 152 0.0041
548 SINUS TACHYCARDIA 58 0.0041
549 LYMPHADENOPATHY 144 0.0041
550 PANCREATITIS ACUTE 91 0.0040
551 DRUG INEFFECTIVE 5321 0.0040
552 PSYCHOMOTOR HYPERACTIVITY 67 0.0040
553 SINUS BRADYCARDIA 39 0.0040
554 SCAB 46 0.0040
555 PRODUCT QUALITY ISSUE 547 0.0040
556 PNEUMONITIS 109 0.0040
557 INTERVERTEBRAL DISC DEGENERATION 37 0.0040
558 PRODUCT DISTRIBUTION ISSUE 37 0.0040
559 RHINORRHOEA 257 0.0040
560 OROPHARYNGEAL PAIN 367 0.0040
561 LYMPHOCYTE COUNT DECREASED 70 0.0040
562 LIMB DISCOMFORT 122 0.0039
563 BLOOD POTASSIUM DECREASED 118 0.0039
564 BLOOD TEST ABNORMAL 55 0.0039
565 INCREASED TENDENCY TO BRUISE 36 0.0039
566 PRODUCT ADMINISTRATION ERROR 79 0.0039
567 CANDIDA INFECTION 66 0.0039
568 IRON DEFICIENCY ANAEMIA 36 0.0039
569 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 203 0.0039
570 APHTHOUS ULCER 30 0.0039
571 AGGRESSION 193 0.0039
572 APPENDICITIS 36 0.0039
573 ECONOMIC PROBLEM 58 0.0038
574 AGITATION 280 0.0038
575 POOR QUALITY SLEEP 82 0.0038
576 VERTIGO 232 0.0038
577 DYSURIA 140 0.0038
578 PARANOIA 65 0.0038
579 BALANCE DISORDER 325 0.0038
580 VIRAL INFECTION 125 0.0038
581 SOMNOLENCE 755 0.0037
582 MUSCULOSKELETAL CHEST PAIN 58 0.0037
583 DYSARTHRIA 141 0.0037
584 LETHARGY 215 0.0037
585 ORTHOSTATIC HYPOTENSION 65 0.0037
586 THERAPY PARTIAL RESPONDER 58 0.0037
587 PERIPHERAL COLDNESS 51 0.0037
588 DIZZINESS POSTURAL 36 0.0037
589 PRODUCT DOSE OMISSION IN ERROR 105 0.0037
590 GASTROENTERITIS 54 0.0037
591 ACCIDENT 44 0.0037
592 DECUBITUS ULCER 30 0.0037
593 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 202 0.0037
594 VENTRICULAR EXTRASYSTOLES 38 0.0037
595 INCORRECT PRODUCT ADMINISTRATION DURATION 79 0.0036
596 ERYTHEMA MULTIFORME 34 0.0036
597 APHASIA 110 0.0036
598 DRY EYE 181 0.0036
599 PULMONARY MASS 54 0.0036
600 DERMATITIS ATOPIC 191 0.0036
601 BRONCHOPULMONARY ASPERGILLOSIS 28 0.0036
602 DYSTONIA 70 0.0036
603 THERAPEUTIC RESPONSE SHORTENED 119 0.0036
604 GLOMERULAR FILTRATION RATE DECREASED 44 0.0036
605 GASTRITIS 94 0.0036
606 TORSADE DE POINTES 28 0.0036
607 HEPATOMEGALY 35 0.0036
608 HEAD DISCOMFORT 63 0.0036
609 SUPRAVENTRICULAR TACHYCARDIA 34 0.0035
610 SEIZURE 410 0.0035
611 BLOOD PRESSURE INCREASED 542 0.0035
612 SCHIZOPHRENIA 43 0.0035
613 ACIDOSIS 27 0.0035
614 RED BLOOD CELL COUNT DECREASED 101 0.0035
615 ANGER 119 0.0035
616 GINGIVAL BLEEDING 48 0.0035
617 PHARYNGITIS STREPTOCOCCAL 38 0.0035
618 INITIAL INSOMNIA 36 0.0035
619 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 36 0.0035
620 GENERALISED TONIC-CLONIC SEIZURE 58 0.0035
621 APATHY 51 0.0035
622 RENAL PAIN 37 0.0035
623 PNEUMONIA BACTERIAL 32 0.0035
624 ILLNESS 359 0.0035
625 SARS-COV-2 TEST POSITIVE 46 0.0035
626 SENSORY LOSS 28 0.0035
627 DYSPHONIA 203 0.0035
628 ALANINE AMINOTRANSFERASE INCREASED 213 0.0035
629 MYASTHENIA GRAVIS 28 0.0035
630 GOUT 62 0.0035
631 CRYING 125 0.0034
632 AFFECT LABILITY 33 0.0034
633 TENDONITIS 53 0.0034
634 LEUKOPENIA 171 0.0034
635 DEHYDRATION 456 0.0034
636 INTENTIONAL DOSE OMISSION 97 0.0034
637 PANIC ATTACK 124 0.0034
638 INFLUENZA 379 0.0034
639 VITAMIN D DECREASED 29 0.0034
640 TACHYPNOEA 46 0.0034
641 CHOKING 66 0.0034
642 BLOOD ALKALINE PHOSPHATASE INCREASED 84 0.0034
643 SYNCOPE 338 0.0034
644 SUICIDAL IDEATION 309 0.0034
645 PLATELET COUNT INCREASED 44 0.0034
646 UNRESPONSIVE TO STIMULI 87 0.0034
647 AGEUSIA 84 0.0034
648 DEMENTIA 94 0.0034
649 CHILLS 394 0.0034
650 CARPAL TUNNEL SYNDROME 47 0.0034
651 BURNING SENSATION 235 0.0033
652 FEELING COLD 93 0.0033
653 GAMMA-GLUTAMYLTRANSFERASE INCREASED 74 0.0033
654 INTENTIONAL OVERDOSE 214 0.0033
655 ACUTE RESPIRATORY DISTRESS SYNDROME 59 0.0033
656 ALTERED STATE OF CONSCIOUSNESS 72 0.0033
657 SEDATION 87 0.0033
658 DISEASE RECURRENCE 158 0.0033
659 MELAENA 73 0.0033
660 HALLUCINATION, VISUAL 70 0.0033
661 HYPOTENSION 665 0.0033
662 CYANOSIS 52 0.0033
663 BRADYCARDIA 175 0.0033
664 OCULAR DISCOMFORT 37 0.0033
665 HAIR COLOUR CHANGES 41 0.0033
666 HEPATIC CYTOLYSIS 42 0.0033
667 OVERDOSE 709 0.0033
668 ACCIDENTAL OVERDOSE 120 0.0033
669 HEPATIC STEATOSIS 61 0.0033
670 MOOD ALTERED 89 0.0033
671 HAEMOPTYSIS 91 0.0033
672 FEEDING DISORDER 66 0.0033
673 MICTURITION URGENCY 37 0.0032
674 CHOLESTASIS 62 0.0032
675 ORAL HERPES 63 0.0032
676 SKIN LACERATION 35 0.0032
677 CLOSTRIDIUM DIFFICILE INFECTION 70 0.0032
678 ATAXIA 38 0.0032
679 CELLULITIS 161 0.0032
680 INCREASED APPETITE 61 0.0032
681 CHOLECYSTITIS 38 0.0032
682 BLOOD SODIUM DECREASED 60 0.0032
683 HOSPITALISATION 489 0.0032
684 FALL 1058 0.0032
685 TOXICITY TO VARIOUS AGENTS 536 0.0032
686 EYE DISORDER 104 0.0032
687 THERAPY CHANGE 31 0.0031
688 ASPARTATE AMINOTRANSFERASE INCREASED 167 0.0031
689 URINARY TRACT INFECTION 536 0.0031
690 BLOOD POTASSIUM INCREASED 51 0.0031
691 MOTOR DYSFUNCTION 32 0.0031
692 MUSCULOSKELETAL DISCOMFORT 54 0.0031
693 THIRST 56 0.0031
694 RESPIRATORY DISTRESS 86 0.0031
695 CLOSTRIDIUM DIFFICILE COLITIS 33 0.0031
696 LOSS OF CONSCIOUSNESS 396 0.0031
697 PARKINSONISM 30 0.0031
698 KIDNEY INFECTION 60 0.0031
699 DERMATITIS 64 0.0031
700 SENSORY DISTURBANCE 49 0.0031
701 DRY THROAT 31 0.0030
702 HEART RATE DECREASED 107 0.0030
703 HOSPICE CARE 30 0.0030
704 NERVE COMPRESSION 28 0.0030
705 RESTLESSNESS 111 0.0030
706 DELUSION 47 0.0030
707 EYELID OEDEMA 35 0.0030
708 IRRITABILITY 181 0.0030
709 MASS 42 0.0030
710 ANAL INCONTINENCE 27 0.0030
711 PAIN IN JAW 85 0.0030
712 HYPERSOMNIA 86 0.0030
713 HYPERBILIRUBINAEMIA 31 0.0030
714 BLOOD CREATININE INCREASED 195 0.0030
715 LYMPHOPENIA 42 0.0030
716 EJECTION FRACTION DECREASED 46 0.0030
717 PULMONARY CONGESTION 39 0.0030
718 NEUROPATHY PERIPHERAL 281 0.0030
719 CYSTITIS 94 0.0029
720 BLOOD IRON DECREASED 35 0.0029
721 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 527 0.0029
722 NEPHROLITHIASIS 133 0.0029
723 PNEUMOCYSTIS JIROVECII PNEUMONIA 29 0.0029
724 INSURANCE ISSUE 44 0.0029
725 MYALGIA 489 0.0029
726 SEPTIC SHOCK 125 0.0029
727 PALLOR 78 0.0029
728 APHONIA 40 0.0029
729 BONE LOSS 43 0.0029
730 HAEMATOMA 74 0.0029
731 RESPIRATORY DEPRESSION 35 0.0029
732 MOOD SWINGS 91 0.0029
733 RENAL FAILURE 379 0.0029
734 BACTERIAL INFECTION 53 0.0028
735 SKIN HAEMORRHAGE 42 0.0028
736 HYPERGLYCAEMIA 103 0.0028
737 FUNGAL INFECTION 94 0.0028
738 FLUSHING 286 0.0028
739 HEAD INJURY 89 0.0028
740 PLEURAL EFFUSION 170 0.0028
741 ACUTE HEPATIC FAILURE 38 0.0028
742 RASH GENERALISED 72 0.0028
743 HAEMATOCRIT DECREASED 55 0.0028
744 DRY SKIN 370 0.0028
745 SMALL INTESTINAL OBSTRUCTION 34 0.0028
746 EPISTAXIS 206 0.0028
747 BONE DENSITY DECREASED 86 0.0027
748 THINKING ABNORMAL 51 0.0027
749 ORAL DISCOMFORT 38 0.0027
750 TOOTH INFECTION 36 0.0027
751 PRODUCT DOSE OMISSION ISSUE 802 0.0027
752 RENAL INJURY 81 0.0027
753 TREMOR 452 0.0027
754 HAEMORRHOIDS 53 0.0027
755 MOVEMENT DISORDER 87 0.0027
756 MYOCARDITIS 31 0.0027
757 FEELING ABNORMAL 647 0.0027
758 BACTERAEMIA 32 0.0027
759 COMA 128 0.0027
760 CARDIOMEGALY 33 0.0027
761 SKIN EXFOLIATION 226 0.0027
762 SKIN DISCOLOURATION 123 0.0027
763 ANAEMIA 509 0.0027
764 COLD SWEAT 47 0.0027
765 PANCYTOPENIA 149 0.0027
766 DEVICE RELATED INFECTION 41 0.0027
767 SKIN FISSURES 52 0.0027
768 HEMIPARESIS 45 0.0027
769 LEUKOCYTOSIS 48 0.0026
770 BLOOD PRESSURE DECREASED 176 0.0026
771 LIVER FUNCTION TEST ABNORMAL 77 0.0026
772 SPLENOMEGALY 31 0.0026
773 FOOT FRACTURE 50 0.0026
774 BONE DISORDER 48 0.0026
775 RESPIRATORY FAILURE 192 0.0026
776 FAECES DISCOLOURED 57 0.0026
777 MALNUTRITION 29 0.0026
778 PRODUCT AVAILABILITY ISSUE 59 0.0026
779 PRODUCT TASTE ABNORMAL 35 0.0026
780 FEELING JITTERY 49 0.0026
781 ATRIAL FIBRILLATION 250 0.0026
782 ENCEPHALOPATHY 63 0.0026
783 CATARACT 152 0.0025
784 HOT FLUSH 192 0.0025
785 HYPOTHYROIDISM 81 0.0025
786 DIVERTICULITIS 70 0.0025
787 TRANSAMINASES INCREASED 56 0.0025
788 HYPOGLYCAEMIA 122 0.0025
789 PULMONARY ARTERIAL HYPERTENSION 36 0.0025
790 CARDIAC ARREST 205 0.0025
791 EYE INFECTION 28 0.0025
792 RIB FRACTURE 51 0.0025
793 HEART RATE IRREGULAR 56 0.0025
794 DRUG LEVEL INCREASED 41 0.0025
795 PRODUCT USE COMPLAINT 39 0.0025
796 NEURALGIA 60 0.0025
797 THERAPY INTERRUPTED 176 0.0025
798 SEROTONIN SYNDROME 47 0.0024
799 THERAPY CESSATION 125 0.0024
800 FULL BLOOD COUNT DECREASED 49 0.0024
801 HEPATOTOXICITY 54 0.0024
802 RHABDOMYOLYSIS 101 0.0024
803 WRIST FRACTURE 29 0.0024
804 FLUID OVERLOAD 35 0.0024
805 IMPAIRED WORK ABILITY 51 0.0024
806 SUBDURAL HAEMATOMA 34 0.0024
807 BONE PAIN 139 0.0024
808 PSYCHOTIC DISORDER 70 0.0024
809 RENAL IMPAIRMENT 199 0.0024
810 SUICIDE ATTEMPT 143 0.0024
811 ABNORMAL DREAMS 65 0.0024
812 SEPSIS 262 0.0023
813 SPEECH DISORDER 123 0.0023
814 EMOTIONAL DISTRESS 283 0.0023
815 INTERVERTEBRAL DISC PROTRUSION 51 0.0023
816 COMPLETED SUICIDE 194 0.0023
817 EYE IRRITATION 134 0.0023
818 VISION BLURRED 317 0.0023
819 HYPOPHAGIA 59 0.0023
820 BRAIN OEDEMA 29 0.0023
821 LIMB INJURY 62 0.0023
822 COAGULOPATHY 38 0.0023
823 DYSSTASIA 66 0.0023
824 MULTIPLE ORGAN DYSFUNCTION SYNDROME 64 0.0023
825 DIABETES MELLITUS INADEQUATE CONTROL 40 0.0023
826 ROTATOR CUFF SYNDROME 29 0.0023
827 TREATMENT NONCOMPLIANCE 123 0.0022
828 SKIN ULCER 58 0.0022
829 FLATULENCE 127 0.0022
830 POST PROCEDURAL COMPLICATION 43 0.0022
831 DYSKINESIA 91 0.0022
832 FEAR 60 0.0022
833 CHOLELITHIASIS 73 0.0022
834 SCAR 38 0.0022
835 LOCAL SWELLING 38 0.0022
836 ACUTE MYOCARDIAL INFARCTION 64 0.0022
837 MUSCLE TIGHTNESS 35 0.0022
838 CARDIOGENIC SHOCK 31 0.0022
839 INJECTION SITE INDURATION 28 0.0022
840 PRODUCT SUBSTITUTION ISSUE 124 0.0022
841 CARDIO-RESPIRATORY ARREST 90 0.0022
842 BLOOD BILIRUBIN INCREASED 58 0.0021
843 NEUTROPENIA 291 0.0021
844 ARRHYTHMIA 101 0.0021
845 LACTIC ACIDOSIS 69 0.0021
846 ABNORMAL BEHAVIOUR 84 0.0021
847 HAEMOGLOBIN DECREASED 216 0.0021
848 PULMONARY OEDEMA 94 0.0021
849 STAPHYLOCOCCAL INFECTION 69 0.0021
850 GALLBLADDER DISORDER 37 0.0021
851 PULMONARY HYPERTENSION 43 0.0021
852 MENTAL STATUS CHANGES 57 0.0021
853 GASTRIC ULCER 39 0.0020
854 DYSGEUSIA 152 0.0020
855 OCULAR HYPERAEMIA 97 0.0020
856 CARDIAC FAILURE 164 0.0020
857 PNEUMONIA ASPIRATION 51 0.0020
858 GLAUCOMA 39 0.0020
859 EXPIRED PRODUCT ADMINISTERED 67 0.0020
860 SKIN DISORDER 67 0.0020
861 HYPERTHYROIDISM 29 0.0020
862 AGRANULOCYTOSIS 37 0.0020
863 DEAFNESS 52 0.0020
864 INTERNATIONAL NORMALISED RATIO INCREASED 56 0.0020
865 UPPER GASTROINTESTINAL HAEMORRHAGE 33 0.0020
866 BLOOD URINE PRESENT 37 0.0019
867 RENAL DISORDER 90 0.0019
868 PRODUCT PRESCRIBING ERROR 46 0.0019
869 LUNG INFECTION 30 0.0019
870 CEREBRAL HAEMORRHAGE 69 0.0019
871 EATING DISORDER 41 0.0019
872 NERVOUS SYSTEM DISORDER 60 0.0019
873 DEPRESSED LEVEL OF CONSCIOUSNESS 76 0.0019
874 UPPER LIMB FRACTURE 38 0.0019
875 MENTAL DISORDER 83 0.0019
876 NERVOUSNESS 99 0.0019
877 INJECTION SITE RASH 58 0.0019
878 ABSCESS 30 0.0019
879 ANKLE FRACTURE 29 0.0019
880 PULMONARY EMBOLISM 177 0.0019
881 HERNIA 36 0.0019
882 PERICARDIAL EFFUSION 43 0.0019
883 PLATELET COUNT DECREASED 198 0.0019
884 CARDIOVASCULAR DISORDER 47 0.0018
885 SPINAL FRACTURE 37 0.0018
886 POLLAKIURIA 77 0.0018
887 TOOTH LOSS 38 0.0018
888 INTESTINAL OBSTRUCTION 69 0.0018
889 EYE PAIN 103 0.0018
890 NEEDLE ISSUE 53 0.0018
891 LOCALISED INFECTION 44 0.0018
892 ABORTION SPONTANEOUS 72 0.0018
893 BASAL CELL CARCINOMA 28 0.0018
894 EMOTIONAL DISORDER 55 0.0018
895 DISEASE PROGRESSION 211 0.0018
896 HAEMATEMESIS 45 0.0018
897 TOOTHACHE 32 0.0018
898 PNEUMOTHORAX 28 0.0018
899 INFLUENZA LIKE ILLNESS 145 0.0018
900 BLOOD GLUCOSE INCREASED 328 0.0017
901 BLOOD CREATINE PHOSPHOKINASE INCREASED 50 0.0017
902 MENTAL IMPAIRMENT 42 0.0017
903 WHITE BLOOD CELL COUNT DECREASED 187 0.0017
904 HERPES ZOSTER 99 0.0017
905 INJECTION SITE SWELLING 132 0.0017
906 DIABETIC KETOACIDOSIS 41 0.0017
907 RESPIRATORY ARREST 47 0.0017
908 PRODUCT DISPENSING ERROR 37 0.0017
909 HAEMATURIA 58 0.0017
910 ISCHAEMIC STROKE 30 0.0017
911 ERECTILE DYSFUNCTION 43 0.0017
912 OSTEONECROSIS 55 0.0017
913 MULTIPLE SCLEROSIS 80 0.0017
914 HEPATIC FAILURE 50 0.0017
915 PRODUCT PRESCRIBING ISSUE 36 0.0017
916 GASTRIC DISORDER 56 0.0016
917 HYPOACUSIS 69 0.0016
918 METABOLIC ACIDOSIS 51 0.0016
919 NEUTROPHIL COUNT DECREASED 65 0.0016
920 DIABETES MELLITUS 121 0.0016
921 GLYCOSYLATED HAEMOGLOBIN INCREASED 40 0.0016
922 GASTROINTESTINAL HAEMORRHAGE 132 0.0016
923 HAEMORRHAGE 165 0.0016
924 MYOCARDIAL INFARCTION 274 0.0016
925 CARDIAC FAILURE CONGESTIVE 124 0.0015
926 AMENORRHOEA 27 0.0015
927 DEEP VEIN THROMBOSIS 100 0.0015
928 LUNG NEOPLASM MALIGNANT 63 0.0015
929 THROMBOSIS 123 0.0015
930 NO ADVERSE EVENT 277 0.0015
931 ANGINA PECTORIS 43 0.0015
932 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 34 0.0015
933 INTERSTITIAL LUNG DISEASE 70 0.0014
934 SKIN IRRITATION 66 0.0014
935 SKIN BURNING SENSATION 103 0.0014
936 PLASMA CELL MYELOMA 56 0.0014
937 HIP FRACTURE 46 0.0014
938 PRODUCT DOSE OMISSION 93 0.0014
939 BLOOD PRESSURE ABNORMAL 28 0.0014
940 EXTRA DOSE ADMINISTERED 57 0.0014
941 JOINT INJURY 30 0.0014
942 PREMATURE BABY 42 0.0014
943 BLOOD GLUCOSE DECREASED 67 0.0014
944 SKIN CANCER 30 0.0014
945 EXPOSURE VIA SKIN CONTACT 36 0.0014
946 INCORRECT DOSE ADMINISTERED 317 0.0014
947 BONE MARROW FAILURE 28 0.0014
948 THERAPEUTIC RESPONSE UNEXPECTED 61 0.0014
949 GYNAECOMASTIA 42 0.0014
950 UNEVALUABLE EVENT 101 0.0013
951 INJECTION SITE BRUISING 105 0.0013
952 INJECTION SITE ERYTHEMA 163 0.0013
953 INJECTION SITE PRURITUS 88 0.0013
954 ABDOMINAL PAIN LOWER 33 0.0013
955 INJECTION SITE URTICARIA 32 0.0013
956 TOOTH DISORDER 29 0.0013
957 OSTEONECROSIS OF JAW 30 0.0012
958 DEVICE DELIVERY SYSTEM ISSUE 33 0.0012
959 CARDIAC DISORDER 112 0.0012
960 CORONARY ARTERY DISEASE 36 0.0012
961 NEOPLASM PROGRESSION 41 0.0012
962 TARDIVE DYSKINESIA 32 0.0011
963 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 229 0.0011
964 DRUG WITHDRAWAL SYNDROME 99 0.0011
965 INJECTION SITE PAIN 345 0.0011
966 VISUAL ACUITY REDUCED 37 0.0011
967 ACNE 83 0.0011
968 SURGERY 64 0.0011
969 ASCITES 32 0.0011
970 DRUG DEPENDENCE 165 0.0010
971 DRUG EFFECT INCOMPLETE 37 0.0010
972 DEATH 868 0.0010
973 MALIGNANT NEOPLASM PROGRESSION 102 0.0010
974 RENAL FAILURE ACUTE 42 0.0010
975 DEVICE ISSUE 87 0.0010
976 HEPATIC FUNCTION ABNORMAL 36 0.0010
977 MULTIPLE SCLEROSIS RELAPSE 65 0.0009
978 VAGINAL HAEMORRHAGE 39 0.0009
979 DEVICE MALFUNCTION 63 0.0009
980 INJECTION SITE MASS 33 0.0009
981 CONVULSION 51 0.0009
982 DEVICE LEAKAGE 37 0.0009
983 CEREBROVASCULAR ACCIDENT 137 0.0008
984 BREAST CANCER 74 0.0008
985 ACCIDENTAL EXPOSURE TO PRODUCT 80 0.0008
986 WRONG TECHNIQUE IN DRUG USAGE PROCESS 28 0.0008
987 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 53 0.0007
988 DRUG DOSE OMISSION 123 0.0007
989 DRUG DOSE OMISSION BY DEVICE 55 0.0007
990 NEOPLASM MALIGNANT 45 0.0007
991 DRUG EFFECT DECREASED 36 0.0007
992 PRODUCT STORAGE ERROR 57 0.0007
993 INJECTION SITE HAEMORRHAGE 52 0.0007